Loading...
Relevance of the immunoglobulin V(H) somatic mutation status in patients with chronic lymphocytic leukemia treated with fludarabine, cyclophosphamide, and rituximab (FCR) or related chemoimmunotherapy regimens
Although immunoglobulin V(H) mutation status (IgV(H) MS) is prognostic in patients with chronic lymphocytic leukemia (CLL) who are treated with alkylating agents or single-agent fludarabine, its significance in the era of chemoimmunotherapy is not known. We determined the IgV(H) somatic mutation sta...
Na minha lista:
| Udgivet i: | Blood |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society of Hematology
2009
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4916943/ https://ncbi.nlm.nih.gov/pubmed/19050308 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2008-10-184853 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|